2,493
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Vasorelaxant properties of Vernonia amygdalina ethanol extract and its possible mechanism

ORCID Icon, , ORCID Icon, , , & show all
Pages 2083-2094 | Received 05 Feb 2016, Accepted 17 Jul 2017, Published online: 23 Aug 2017

References

  • Agbogidi O, Akpomorine M. 2013. Health and nutritional benefits of bitter leaf (Vernonia amygdalina Del). Int J Basic Appl Med Sci. 2:164–170.
  • Ameer OZ, Salman IM, Siddiqui MJA, Yam MF, Sriramaneni RN, Mohamed AJ, Sadikun A, Ismail Z, Shah AM, Asmawi MZ. 2010. Pharmacological mechanisms underlying the vascular activities of Loranthus ferrugineus Roxb. in rat thoracic aorta. J Ethnopharmacol. 127:19–25.
  • Atangwho IJ, Ebong PE, Eyong EU, Asmawi MZ, Ahmad M. 2012. Synergistic antidiabetic activity of Vernonia amygdalina and Azadirachta indica: biochemical effects and possible mechanism. J Ethnopharmacol. 141:878–887.
  • Atangwho IJ, Edet EE, Uti DE, Obi AU, Asmawi MZ, Ahmad M. 2012. Biochemical and histological impact of Vernonia amygdalina supplemented diet in obese rats. Saudi J Biol Sci. 19:385–392.
  • Atangwho IJ, Egbung GE, Ahmad M, Yam MF, Asmawi MZ. 2013. Antioxidant versus anti-diabetic properties of leaves from Vernonia amygdalina Del. growing in Malaysia. Food Chem. 141:3428–3434.
  • Buch JG. 2010. Clinically oriented pharmacology. Rajkot, India: PDU Medical College.
  • Ch’ng YS, Tan CS, Loh YC, Ahmad M, Asmawi MZ, Yam MF. 2016. Vasorelaxation study and tri-step infrared spectroscopy analysis of Malaysian local herbs. J Pharmacopunct. 19:145–154.
  • Damiani CEN, Rossoni LV, Vassallo DV. 2003. Vasorelaxant effects of eugenol on rat thoracic aorta. Vascul Pharmacol. 40:59–66.
  • Dannhardt G, Kiefer W. 2001. Cyclooxygenase inhibitors-current status and future prospects. Eur J Med Chem. 36:109–126.
  • Feletou M, Vanhoutte P. 2005. EDHF: the complete story. Boca Raton (FL): CRC Press.
  • Jakala P, Pere E, Lehtinen R, Turpeinen A, Korpela R, Vapaatalo H. 2009. Cardiovascular activity of milk casein-derived tripeptides and plant sterols in spontaneously hypertensive rats. J Physiol Pharmacol. 60:11–20.
  • Jin SN, Wen JF, Li X, Kang DG, Lee HS, Cho KW. 2011. The mechanism of vasorelaxation induced by ethanol extract of Sophora flavescens in rat aorta. J Ethnopharmacol. 137:547–552.
  • Li D, Jin Z, Zhou Q, Chen J, Lei Y, Sun S. 2010. Discrimination of five species of Fritillaria and its extracts by FT-IR and 2D-IR. J Mol Struct. 974:68–72.
  • Li JR, Sun SQ, Wang XX, Xu CH, Chen JB, Zhou Q, Lu GH. 2014. Differentiation of five species of Danggui raw materials by FTIR combined with 2D-COS IR. J Mol Struct. 1069:229–235.
  • Loh YC, Tan CS, Ch’ng YS, Ahmad M, Asmawi MZ, Yam MF. 2017. Vasodilatory effects of combined traditional Chinese medicinal herbs in optimized ratio. J Med Food. 20:265–278.
  • Louis S. 2011. Goodman & Gilman's pharmacological basis of therapeutics. New York: McGraw-Hill.
  • Luksha L, Agewall S, Kublickiene K. 2009. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis. 202:330–344.
  • Mayer B, Brunner F, Schmidt K. 1993. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 45:367–374.
  • McFadzean I, Gibson A. 2002. The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle. Br J Pharmacol. 135:1–13.
  • Nelson MT, Quayle JM. 1995. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 268:C799–C822.
  • Olaiya C, Choudhary M, Ogunyemi O, Nwauzoma A. 2013. Nutraceuticals from bitter leaf (Vernonia amygdalina Del.) protects against cadmium chloride induced hypertension in albino rats. Nat Sci. 11:136–145.
  • Quasie O, Zhang YM, Zhang HJ, Luo J, Kong LY. 2016. Four new steroid saponins with highly oxidized side chains from the leaves of Vernonia amygdalina. Phytochem Lett. 15:16–20.
  • Rahman ARA. 2013. Clinical practice guidelines: management of hypertension. 4th ed. Malaysia: Ministry of Health Malaysia.
  • Rameshrad M, Babaei H, Azarmi Y, Fouladia DF. 2016. Rat aorta as a pharmacological tool for in vitro and in vivo studies. Life Sci. 145:190–204.
  • Rampal L, Rampal S, Azhar M, Rahman AR. 2008. Prevalence, awareness, treatment and control of hypertension in Malaysia: a national study of 16,440 subjects. Public Health. 122:11–18.
  • Senejoux F, Demougeot C, Cuciureanu M, Miron A, Cuciureanu R, Berthelot A, Girard-Thernier C. 2013. Vasorelaxant effects and mechanisms of action of Heracleum sphondylium L. (Apiaceae) in rat thoracic aorta. J Ethnopharmacol. 147:536–539.
  • Senejoux F, Girard C, Kerram P, Aisa HA, Berthelot A, Bévalot F, Demougeot C. 2010. Mechanisms of vasorelaxation induced by Ziziphora clinopodioides Lam. (Lamiaceae) extract in rat thoracic aorta. J Ethnopharmacol. 132:268–273.
  • Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 69:145–182.
  • Sun SQ, Zhou Q, Chen JB. 2010. Analysis of traditional Chinese medicine by infrared spectroscopy. Beijing, China: Chemical Industrial Press.
  • Taiwo IA, Odeigah PGC, Jaja S, Mojiminiyi F. 2010. Cardiovascular effects of Vernonia amygdalina in rats and the implications for treatment of hypertension in diabetes. Researcher. 2:76–79.
  • Tan CS, Loh YC, Ch’ng YS, Mariam A, Mohd ZA, Yam MF. 2017. Decomposition and reformulation of Banxia Baizhu Tianma decoction: a vasodilatory approach. Chin Herb Med. 9:134–146.
  • Tan CS, Ch’ng YS, Loh YC, Mohd. ZA, Mariam A, Yam MF. 2017. Vasorelaxation effect of Glycyrrhizae uralensis through the endothelium-dependent pathway. J Ethnopharmacol. 199, 149–160.
  • Walch L, Gascard JP, Dulmet E, Brink C, Norel X. 2000. Evidence for a M(1) muscarinic receptor on the endothelium of human pulmonary veins. Br J Pharmacol. 130:73–78.
  • Wang HP, Lu JF, Zhang GL, Li XY, Peng HY, Lu Y, Zhao L, Ye ZG, Bruce IC, Xia Q. 2014. Endothelium-dependent and -independent vasorelaxant actions and mechanisms induced by total flavonoids of Elsholtzia splendens in rat aortas. Environ Toxicol Pharmacol. 38:453–459.
  • Wang J, Dong MQ, Liu ML, Xu DQ, Luo Y, Zhang B, Liu LL, Xu M, Zhao PT, Gao YQ. 2010. Tanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension rats. Eur J Pharmacol. 640:129–138.
  • Wang R. 2009. Hydrogen sulfide: a new EDRF. Kidney Int. 76:700–704.
  • Yildiz O, Gul H, Seyrek M. 2013. Pharmacology of arterial grafts for coronary artery bypass surgery. Rijeka, Croatia: INTECH Open Access Publisher.